BioFire scores CE mark for sepsis blood Dx

European authorities granted a CE mark to BioFire Diagnostics for its blood test that can identify more than 100 pathogens known to cause sepsis, which has a mortality rate between 10% and 38%. The FilmArray Blood Culture Identification Panel helps speed up diagnosis of the condition, which becomes more dangerous when left untreated, according to a BioFire release. The diagnostic is the only test that offers positive results for gram-positive bacteria, gram-negative bacteria and yeast-causing bloodstream infections, as well as antimicrobial resistance genes. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.